Özellikli Gruplarda ve Kronik Sağlık Sorunu Olan Bireylerde Kontrasepsiyon

Öz

Doğurganlığın düzenlenmesi ve aile planlaması kavramları birbiri yerine kullanılan oldukça kapsamlı kavramlardır. Doğurganlığın düzenlenmesi hizmeti; riskli ve istenmeyen gebeliklerin önlenmesinin yanı sıra gebelik planlayan çiftler için ovulasyon zamanının belirlenmesinde önemli rol oynar. Sağlık bakım profesyonelleri tarafından sunulan kaliteli, etkin ve sürekli doğurganlığın düzenlenmesi hizmeti; adolesanlar, postpartum dönemdeki kadınlar, perimenopozal dönemdeki kadınlar, engelli kadınlar, mülteci kadınlar, erkekler gibi özellikli gruplarda ve kronik sağlık sorunu olan bireylerde morbidite ve mortalite oranlarının en aza indirilmesinde önemli rol oynayan koruyucu bir sağlık hizmetidir. Kullanılan kontrasepsiyon yönteminin sürekliliği ve etkinliği bireye özgü sunulan danışmanlık hizmeti ile yakından ilişkilidir. Bu nedenle sağlık bakım profesyonelleri özellikli gruplara ve kronik sağlık sorunu olan bireylere özgü doğurganlığın düzenlenmesi hizmeti vermelidir. Doğurganlığın düzenlenmesi yöntemleri ile ilgili birçok çalışma olmasına rağmen özellikli grupların ve kronik sağlık sorunu olan bireylerin kontraseptif yöntem seçimine dair yapılan çalışma sayısı sınırlıdır. Bu bağlamda özellikli gruplara ve kronik sağlık sorunu olan bireylere yönelik uygun kontraseptif yöntemin belirlenmesine ve bu bireylere verilecek danışmanlık hizmetine yönelik çalışmalara ihtiyaç vardır. Bu derlemede amaç özellikli gruplara ve kronik sağlık sorunu olan bireylere uygun kontraseptif yöntemleri irdelemek ve sağlık bakım profesyonellerine yönelik güncel bir kaynak oluşturmaktır.

Anahtar Kelimeler

• aile planlaması
• kontrasepsiyon
• adolesan
• postpartum dönem
• perimenopoz
• kronik hastalık

Contraception in Special Groups and Individuals with Chronic Health Problems

Öz

The concepts of regulation of fertility and family planning are quite comprehensive consepts used interchangeably. Regulation of fertility service plays an important role in determining ovulation time for couples planning pregnancy as well as preventing risky and unwanted pregnancies. Quality, effective and continuous regulation of fertility services provided by health care professionals is a preventive health care service that plays a significant role in minimizing morbidity and mortality rates in diverse groups such as adolescents, postpartum women, women near menopause, women with disabilities, refugee women, men and individuals with chronic health problem. The continuity and effectiveness of the contraception method used is closely related to the individual counseling service. Therefore, health care professionals should provide regulation of fertility service to diverse groups and individuals with chronic health problem. The number of studies on the selection of contraceptive methods in diverse groups and individuals with chronic health conditions is limited, despite the fact that there are several studies on regulation of fertility methods. In this context, studies are required to determine the best contraceptive method for diverse groups and individuals with chronic health conditions, as well as to provide consultation services.The aim of this review is to examine appropriate contraceptive methods in diverse groups and individuals with chronic health problem and to compose an up-to-date resource for health care professionals.

Anahtar Kelimeler

• family planning
• contraception
• adolescent
• postpartum period
• perimenopause
• chronic disease

Kaynakça

1. World Health Organisation (WHO). Family Planning: A Global Handbook for Providers 2018 Edition. [Internet]. 2018. [Erişim tarihi: 20 Kasım 2019]. https://apps.who.int/iris/bitstream/handle/10665/260156/9780999203705-eng.pdf?sequence=1
2. United Nations Population Fund (UNFPA). Family planning. [Internet]. [Erişim tarihi: 20 Kasım 2019]. https://www.unfpa.org/family-planning
3. World Health Organisation (WHO). Family planning/Contraception. [Internet]. 2018. [Erişim tarihi: 20 Kasım 2019]. https://www.who.int/news-room/fact-sheets/detail/family-planning-contraception
4. Colquitt CW, Martin TS. Contraceptive methods: A review of nonbarrier and barrier products. Journal of pharmacy practice 2017; 30(1), 130-135.
5. Hubacher D, Spector H, Monteith C, Chen PL, Hart C. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. American journal of obstetrics and gynecology 2017; 216(2), 101-109.
6. American College of Obstetricians and Gynecologists (ACOG). Barrier Methods of Birth Control. Spermicide, Condom, Sponge, Diaphragm and Cervical Cup. [Internet]. 2018. [Erişim tarihi: 20 Kasım 2019]. https://www.acog.org/Patients/FAQs/Barrier-Methods-of-Birth-Control-Spermicide-Condom-Sponge-Diaphragm-and-Cervical-Cap?IsMobileSet=false
7. Faculty of Sexual & Reproductive Healthcare (FSRH). For Contraceptive Use. UKMEC 2016. [Internet]. 2019. [Erişim tarihi: 20 Kasım 2019]. https://www.fsrh.org/standards-and-guidance/documents/ukmec-2016/
8. Ontiri S, Ndirangu G, Kabue M, Biesma R, Stekelenburg J, Ouma C. Long-Acting Reversible Contraception Uptake and Associated Factors among Women of Reproductive Age in Rural Kenya. International journal of environmental research and public health 2019; 16(9), 1543.

9. Beji NK. (Ed.). Hemşire ve Ebelere Yönelik Kadın Sağlığı ve Hastalıkları Genişletilmiş 2. Baskı. İstanbul: Nobel Tıp; 2016.
10. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü. Türkiye Nüfus ve Sağlık Araştırması 2018. [Internet]. 2019. [Erişim tarihi: 21 Kasım 2019]. http://www.hips.hacettepe.edu.tr/tnsa2018/rapor/TNSA_2018_anarapor.pdf
11. World Health Organisation (WHO). Medical Eligibility Criteria for Contraceptive Use Fifth Edition 2015. [Internet]. 2015. [Erişim tarihi: 21 Kasım 2019]. https://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/
12. Centers for Disease Control and Prevention (CDC). Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria for Contraceptive Use. [Internet]. 2016. [Erişim tarihi: 21 Kasım 2019]. https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6503.pdf
13. World Health Organisation (WHO). Maternal, newborn, child and adolescent health. Achieving universal health coverage for the world’s 1.2 billion adolescents. [Internet]. [Erişim tarihi: 20 Kasım 2019]. https://www.who.int/maternal_child_adolescent/adolescence/universal-health-coverage/en/
14. World Health Organisation (WHO). Adolescent Pregnancy. [Internet]. 2019. [Erişim tarihi: 21 Kasım 2019]. https://www.who.int/news-room/fact-sheets/detail/adolescent-pregnancy
15. Özgü E, Yakut Hİ. Adolesan Kontrasepsiyon. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 2015; 12(5), 191-193.
16. Kalamar AM, Tunçalp Ö, Hindin MJ. Developing strategies to address contraceptive needs of adolescents: exploring patterns of use among sexually active adolescents in 46 low- and middle-income countries. Contraception 2018; 98(1), 36–40.
17. Centers for Disease Control and Prevention (CDC). Summary chart of US medical eligibility criteria for contraceptive use. [Internet]. [Erişim tarihi: 21 Kasım 2019]. https://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf
18. Taub RL, Jensen JT. Advances in contraception: new options for postpartum women. Expert Opinion on Pharmacotherapy 2017; 18(7), 677–688.
19. Sözbir ŞY, Herek B, Boğa ME, Koçak G, Akbaş P. Postpartum İlk 48 Saatte Verilen Aile Planlaması Eğitiminin Yöntem Seçimi ve Kullanımına Etkisinin Değerlendirilmesi. Gazi Sağlık Bilimleri Dergisi 2019; 4(1), 29-39.
20. Faculty of Sexual & Reproductive Healthcare (FSRH). FSRH Guideline: Contraception for Women Aged Over 40 Years. [Internet]. 2019. [Erişim tarihi: 21 Kasım 2019]. https://www.fsrh.org/standards-and-guidance/documents/fsrh-guidance-contraception-for-women-aged-over-40-years-2017/
21. Australian Family Physician (AFP). Perimenopausal contraception: A practice-based approach. [Internet]. 2017. [Erişim tarihi: 21 Kasım 2019]. https://www.racgp.org.au/afp/2017/june/perimenopausal-contraception-a-practice-based-approach/
22. Centers for Disease Control and Prevention (CDC). Disability and Health Overview Impairments, Activity Limitations, and Participation Restrictions. [Internet]. 2019. [Erişim tarihi: 21 Kasım 2019]. https://www.cdc.gov/ncbddd/disabilityandhealth/disability.html
23. Cangöl E, Karaca P, Aslan E. Engelli bireylerde cinsel sağlık. Androloji Bülteni 2013; 53(1), 141-146.
24. World Health Organisation (WHO). Disability. World report on disability. [Internet]. 2011. [Erişim tarihi: 21 Kasım 2019]. https://www.who.int/disabilities/world_report/2011/report.pdf
25. World Health Organisation (WHO). Selected practice recommendations for contraceptive use. Third Edition 2016. [Internet]. 2016. [Erişim tarihi: 21 Kasım 2019]. https://www.who.int/reproductivehealth/publications/family_planning/SPR-3/en/
26. Yağmur Y, Aytekin S. Mülteci Kadınların Üreme Sağlığı Sorunları ve Çözüm Önerileri. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi 2018; 11 (1), 56-60.
27. Islam MM, Gagnon, AJ. Use of reproductive health care services among urban migrant women in Bangladesh. BMC Women's Health 2016; 16 (1), 15.
28. World Health Organisation (WHO). Migrant women’s health issues: addressing barriers to access to health care for migrant women with irregular status. [Internet]. 2016. [Erişim tarihi: 11 Aralık 2019]. http://www.euro.who.int/__data/assets/pdf_file/0017/330092/6-Migrant-womens-health-issues-irregular-status.pdf?ua=1
29. World Health Organisation (WHO). Improving family planning service delivery in humanitarian crises. [Internet]. 2017. [Erişim tarihi: 11 Aralık 2019]. https://apps.who.int/iris/bitstream/handle/10665/255864/WHO-RHR-17.13-eng.pdf?sequence=1
30. Gava G, Meriggiola MC. Update on male hormonal contraception. Therapeutic advances in endocrinology and metabolism 2019; 10, 2042018819834846.
31. Reynolds-Wright JJ, Anderson RA. Male contraception: where are we going and where have we been? BMJ sexual & reproductive health 2019; 45(4), 236-242.
32. Ross J, Hardee K. Use of male methods of contraception worldwide. Journal of biosocial science 2017; 49(5), 648-663.
33. Şat SÖ, Erenel AŞ, Sözbir ŞY. Özellikli Gruplarda Kontrasepsiyon Danışmanlığı. SDÜ Sağlık Bilimleri Dergisi 2019; 10(2), 190-197.
34. Roth MY, Page ST, Bremner WJ. Male hormonal contraception: looking back and moving forward. Andrology 2016; 4(1), 4-12.
35. Plana O. Male contraception: research, new methods, and implications for marginalized populations. American journal of men's health 2017; 11(4), 1182-1189.
36. Ayoub R, Page ST, Swerdloff RS, Liu PY, Amory JK, Leung A, ... Bremner WJ. Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive. Andrology 2017; 5(2), 278-285.
37. Wu S, Yuen F, Swerdloff RS, Pak Y, Thirumalai A, Liu PY, ... Anawalt BD. Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11 β-Methyl-19-Nortestosterone-17 β-Dodecylcarbonate in Men. The Journal of Clinical Endocrinology & Metabolism 2018; 104(3), 629-638.
38. Duman M, Taşhan ST, Serin EK. Kronik Hastalığı Olan Kadınların Üreme Sağlığı Davranışlarının İncelenmesi. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi 2019; 6(2), 83-91.
39. Faculty of Sexual & Reproductive Healthcare (FSRH). FSRH Guideline: Overweight, Obesite & Contraception. [Internet]. [Erişim tarihi: 21 Kasım 2019]. https://www.fsrh.org/standards-and-guidance/documents/fsrh-clinical-guideline-overweight-obesity-and-contraception/
40. Dehlendorf C., Krajewski C., Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clinical obstetrics and gynecology. 2014;57(4), 659.
41. Dehlendorf C., Henderson JT., Vittinghoff E., Grumbach K., Levy K., Schmittdiel J. et al. Association of the quality of interpersonal care during family planning counseling with contraceptive use. American journal of obstetrics and gynecology. 2016; 215(1), 78-e1.
42. Rodriguez J., Abutouk M., Roque K., Sridhar A. Personalized contraceptive counseling: helping women make the right choice. Open access journal of contraception. 2016; 7, 89.
43. Cavallaro FL., Benova L., Owolabi OO., Ali M. A systematic review of the effectiveness of counselling strategies for modern contraceptive methods: what works and what doesn’t?.BMJ sexual & reproductive health. 2020; 46(4), 254-269.
44. Yurdakul M., Çobaner AA. Üreme sağlığı ve aile planlaması hizmetlerinde sağlık eğitimi, iletişim ve danışmanlık. Turkiye klinikleri j obstet womens health dis nurs-special topics. 2015;1(2).
45. Contraceptive Action Plan. Promoting Knowledge and Opportunity. Contraceptive Counseling Model. [İnternet]. [Erişim tarihi: 13 Mart 2021]. https://www.contraceptiveactionplan.org/index.php/tools-and-resources-menu-item/cap-5-steps-of-contraceptive-counseling-model